Medicine Description stalevo
stalevo Tablets is a medication that combines carbidopa, entacapone, and levodopa to enhance the therapeutic efficacy in treating Parkinson's disease. Levodopa, a precursor to dopamine, is converted into dopamine in the brain, which helps improve motor function. Carbidopa prevents levodopa from being converted into dopamine outside the brain, ensuring that more levodopa reaches the central nervous system. Entacapone further inhibits the enzyme catechol-O-methyltransferase (COMT), which breaks down levodopa, thus prolonging its action and availability in the brain. This synergistic combination effectively addresses both motor symptoms and fluctuations associated with Parkinson's disease.
Indications and Uses of stalevo Tablets
- Treatment of motor symptoms associated with Parkinson's disease.
- Management of fluctuating responses in patients with advanced Parkinson's disease.
- Improvement of fine motor control and reduction of muscle rigidity.
- Alleviation of movement problems such as tremors and bradykinesia.
- Enhancement of the quality of life in patients with Parkinson's disease.
Side Effects of stalevo Tablets
- Nausea and vomiting
- Dizziness or lightheadedness
- Dyskinesias (involuntary movements)
- Dry mouth
- Sleep disturbances
- Constipation
- Hallucinations
Storage and Handling
Store stalevo Tablets at room temperature, away from moisture and heat. Keep out of the reach of children and do not use after the expiration date printed on the packaging.
Patient Advice and Precautions
Patients should take stalevo Tablets as directed by their healthcare provider, ideally at consistent times relative to meals to optimize absorption. It is essential to report any unusual movements or side effects to a healthcare professional. Regular follow-up appointments are advisable to monitor treatment efficacy and adjust therapy as needed.